Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds : ScienceAlert
Tech and Science

Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds : ScienceAlert

Last updated: July 5, 2025 2:30 am
Share
Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds : ScienceAlert
SHARE

GLP-1 Agonists Show Promise in Alleviating Migraines, Study Suggests

Medications like Ozempic, Wegovy, and Saxenda, originally designed to treat type 2 diabetes, have gained popularity for their weight-loss benefits. However, recent research indicates that these GLP-1 agonists may have additional health benefits beyond weight management.

A pilot trial conducted by researchers at the University of Naples in Italy explored the potential of the GLP-1 agonist liraglutide in reducing migraine frequency and intensity in patients with obesity. The study involved 31 participants with high BMI and frequent or chronic migraines who received daily injections of liraglutide.

The results were promising, with participants experiencing a significant decrease in the number of migraine days per month after 12 weeks of treatment. The mean number of migraine days decreased from 19.8 days to just 10.7 days, indicating a nearly 50% reduction in migraine frequency.

Importantly, the migraine relief observed in the study was independent of factors such as weight loss, age, sex, and concurrent medication use, suggesting that liraglutide may have a direct impact on migraine management.

While further research with larger cohorts and control groups is needed to confirm these findings, the study highlights the potential of GLP-1 agonists like liraglutide as a promising avenue for future migraine treatments.

Understanding the Mechanisms of Action

GLP-1 agonists work by mimicking a natural hormone in the body called glucagon-like peptide-1, which helps regulate blood sugar levels and appetite. These medications have widespread effects throughout the body due to the presence of GLP-1 receptors in various tissues and organs.

Past studies have suggested that GLP-1 agonists may reduce intracranial pressure in the brain, a potential trigger for migraines. Animal models have also shown the effectiveness of these drugs in suppressing migraines.

See also  Ninja's Artisan Electric Pizza Oven: Cheap and Easy as an Air Fryer

While the exact mechanisms behind liraglutide’s migraine-relieving effects are still being elucidated, researchers believe that the reduction in intracranial pressure may play a role in alleviating migraines. Recent animal studies have demonstrated that GLP-1 agonists can reduce fluid in the central nervous system, thereby lowering intracranial pressure.

Potential Implications for Migraine Management

Migraines affect a significant portion of the global population, yet current treatment options do not work for everyone. For individuals with migraines that are unresponsive to conventional therapies, GLP-1 agonists like liraglutide could offer a novel approach to migraine management.

The findings of this pilot trial provide a foundation for larger-scale studies to further investigate the role of GLP-1 agonists in migraine treatment. By targeting mechanisms beyond weight loss and metabolic effects, these medications may offer new hope for migraine sufferers.

The study was published in the journal Headache and underscores the potential of GLP-1 agonists in expanding the therapeutic options for migraine patients.

TAGGED:ChronicDrugsfindsMigrainesOzempicLikeScienceAlerttreatTrial
Share This Article
Twitter Email Copy Link Print
Previous Article ‘NoĚ€stos (Homecoming)’ by Andrea Agostini ‘NoĚ€stos (Homecoming)’ by Andrea Agostini
Next Article Jim Cramer Says “Meta is a Ridiculously Cheap Stock” Jim Cramer Says “Meta is a Ridiculously Cheap Stock”
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

‘Beyond Rude and Disrespectful’: Trump Brutally Ridiculed for Arriving to Charlie Kirk’s Memorial Service Late… Without First Lady Melania By His Side

Sept. 21, 2025, Published 4:25 p.m. ET Add Radar on Google Former President Donald Trump…

September 22, 2025

US nitrous oxide deaths spike by more than 500%, study finds

A recent study has revealed a concerning trend in the United States - a significant…

July 31, 2025

The best portable photo printers 2025, tested and reviewed

Image credit: Hannah Cowton / Foundry Smartphones have excellent cameras, yet the digital images they…

October 6, 2025

Scientists Found a Slime Mold Algorithm, And Asked It to Build a Universe : ScienceAlert

The advancement of technology has led to some incredible discoveries in the field of astrophysics.…

September 24, 2024

Happy Ending: Guatemalan Illegal Alien Deported After Attacking and Injuring Endangered Great White Heron – Bird Makes Full Recovery (VIDEO) |

Great White Heron Recovers After Assault in Florida A Great White Heron, classified as endangered,…

April 27, 2025

You Might Also Like

AI mania tanks CoreWeave’s Core Scientific acquisition; it buys Python notebook Marimo
Tech and Science

AI mania tanks CoreWeave’s Core Scientific acquisition; it buys Python notebook Marimo

October 31, 2025
How Supermassive Black Holes Can Become Cosmic Nightmares
Tech and Science

How Supermassive Black Holes Can Become Cosmic Nightmares

October 31, 2025
Why identity-first security is the first defense against sophisticated AI-powered social engineering
Tech and Science

Why identity-first security is the first defense against sophisticated AI-powered social engineering

October 31, 2025
Your flight emissions are way higher than carbon calculators suggest
Tech and Science

Your flight emissions are way higher than carbon calculators suggest

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?